[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] [@EgidiusLambrech](/creator/twitter/EgidiusLambrech) "Phase III trial of #rinatabart sesutecan in platinum-resistant ovarian cancer #Genmab $GMAB Rina-S @AngelesSecord"  [@EgidiusLambrech](/creator/x/EgidiusLambrech) on [X](/post/tweet/1942501543065878884) 2025-07-08 08:30:32 UTC XXX followers, XXX engagements "#Genmab $GMAB #AbbVie $ABBV #Epcoritamab #Epkinly #ICML2025"  [@EgidiusLambrech](/creator/x/EgidiusLambrech) on [X](/post/tweet/1935633294336594402) 2025-06-19 09:38:34 UTC XXX followers, 1155 engagements "New #Genmab trial: Study of the Effectiveness and Safety of #Acasunlimab Alone and With Pembrolizumab to Treat Advanced #Melanoma of the Skin That Has Returned After Treatment With an Approved Checkpoint Inhibitor Therapy (ABBIL1TY MELANOMA-07) $GMAB"  [@EgidiusLambrech](/creator/x/EgidiusLambrech) on [X](/post/tweet/1925555019371192368) 2025-05-22 14:11:06 UTC XXX followers, XXX engagements "@BertrandBio it is exactly one of the points Genmab's Jan van de Winkel made when promoting Hexabody-CD38 in one of his conference calls; wouldn't it be fun if JNJ were to reconsider their decision to opt-out of Hexa-CD38 😂"  [@EgidiusLambrech](/creator/x/EgidiusLambrech) on [X](/post/tweet/1922701797832937685) 2025-05-14 17:13:25 UTC XXX followers, XXX engagements "#Acasunlimab an Fc-inert PD-L14-1BB bispecific antibody combined with PD-1 blockade potentiates antitumor immunity via complementary immune modulatory effects $GMAB #Genmab #DuoBody #GEN1046"  [@EgidiusLambrech](/creator/x/EgidiusLambrech) on [X](/post/tweet/1911775214494511503) 2025-04-14 13:35:04 UTC XXX followers, XXX engagements "#DARZALEX (daratumumab) receives the first positive #CHMP opinion for patients with high-risk #smouldering multiple myeloma $JNJ $GMAB #Genmab $HALO #EMA"  [@EgidiusLambrech](/creator/x/EgidiusLambrech) on [X](/post/tweet/1936011823196553444) 2025-06-20 10:42:42 UTC XXX followers, XXX engagements "Results from EPCORE NHL-2 trial of #epcoritamab + R-CHOP for previously untreated DLBCL #Genmab $GMAB #AbbVie $ABBV #Epkinly #ICML2025"  [@EgidiusLambrech](/creator/x/EgidiusLambrech) on [X](/post/tweet/1935625131826745706) 2025-06-19 09:06:08 UTC XXX followers, 1119 engagements "FDA rejects new indication for Columvi Roche Genentech $ABBV $GMAB AbbVie Genmab #Epkinly #Epcoritamab via @onclive"  [@EgidiusLambrech](/creator/x/EgidiusLambrech) on [X](/post/tweet/1947207891301073191) 2025-07-21 08:11:53 UTC XXX followers, XXX engagements "#Acasunlimab + PD-1 Blockade: Combining Forces to Boost Anti-Tumor Immunotherapy @Genmab $GMAB #GEN1046 #DuoBody-PD-L1x4-1BB"  [@EgidiusLambrech](/creator/x/EgidiusLambrech) on [X](/post/tweet/1922546897463435448) 2025-05-14 06:57:54 UTC XXX followers, XXX engagements "#Genmab $GMAB #AbbVie $ABBV #Epcoritamab #Epkinly #ICML2025"  [@EgidiusLambrech](/creator/x/EgidiusLambrech) on [X](/post/tweet/1935633437366645173) 2025-06-19 09:39:08 UTC XXX followers, 1108 engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@EgidiusLambrech
"Phase III trial of #rinatabart sesutecan in platinum-resistant ovarian cancer #Genmab $GMAB Rina-S @AngelesSecord" @EgidiusLambrech on X 2025-07-08 08:30:32 UTC XXX followers, XXX engagements
"#Genmab $GMAB #AbbVie $ABBV #Epcoritamab #Epkinly #ICML2025" @EgidiusLambrech on X 2025-06-19 09:38:34 UTC XXX followers, 1155 engagements
"New #Genmab trial: Study of the Effectiveness and Safety of #Acasunlimab Alone and With Pembrolizumab to Treat Advanced #Melanoma of the Skin That Has Returned After Treatment With an Approved Checkpoint Inhibitor Therapy (ABBIL1TY MELANOMA-07) $GMAB" @EgidiusLambrech on X 2025-05-22 14:11:06 UTC XXX followers, XXX engagements
"@BertrandBio it is exactly one of the points Genmab's Jan van de Winkel made when promoting Hexabody-CD38 in one of his conference calls; wouldn't it be fun if JNJ were to reconsider their decision to opt-out of Hexa-CD38 😂" @EgidiusLambrech on X 2025-05-14 17:13:25 UTC XXX followers, XXX engagements
"#Acasunlimab an Fc-inert PD-L14-1BB bispecific antibody combined with PD-1 blockade potentiates antitumor immunity via complementary immune modulatory effects $GMAB #Genmab #DuoBody #GEN1046" @EgidiusLambrech on X 2025-04-14 13:35:04 UTC XXX followers, XXX engagements
"#DARZALEX (daratumumab) receives the first positive #CHMP opinion for patients with high-risk #smouldering multiple myeloma $JNJ $GMAB #Genmab $HALO #EMA" @EgidiusLambrech on X 2025-06-20 10:42:42 UTC XXX followers, XXX engagements
"Results from EPCORE NHL-2 trial of #epcoritamab + R-CHOP for previously untreated DLBCL #Genmab $GMAB #AbbVie $ABBV #Epkinly #ICML2025" @EgidiusLambrech on X 2025-06-19 09:06:08 UTC XXX followers, 1119 engagements
"FDA rejects new indication for Columvi Roche Genentech $ABBV $GMAB AbbVie Genmab #Epkinly #Epcoritamab via @onclive" @EgidiusLambrech on X 2025-07-21 08:11:53 UTC XXX followers, XXX engagements
"#Acasunlimab + PD-1 Blockade: Combining Forces to Boost Anti-Tumor Immunotherapy @Genmab $GMAB #GEN1046 #DuoBody-PD-L1x4-1BB" @EgidiusLambrech on X 2025-05-14 06:57:54 UTC XXX followers, XXX engagements
"#Genmab $GMAB #AbbVie $ABBV #Epcoritamab #Epkinly #ICML2025" @EgidiusLambrech on X 2025-06-19 09:39:08 UTC XXX followers, 1108 engagements
/creator/twitter::404367469/posts